ANDREW FLOOD et al. [27] reported a greater risk of adenoma recurrence in patients with elevated serum insulin and glucose and an even greater risk of advanced adenoma recurrence in those with elevated glucose; however, some of these findings do not support a role for insulin biomarkers or recurrent CRA [26, 28]. Here, INS is linked to adenoma.